FDA Inspection 1256471 — HCSC Blood Center

HCSC Blood Center — FEI 3014255385

The FDA completed an inspection of HCSC Blood Center on Dec 6, 2024 in Ewing, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Dec 6, 2024
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Ewing, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.